Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2069	Oooooooh, man, and I was going to throw away that thirty year old Mazola. Next	scaram(o)uche	-	4/4/2004
2068	We do consume reasonably large quantities of butyric acid daily with food (signi	hmpa	-	4/4/2004
2067	>> The main purpose of the drug seems to be to support Titan's funding	scaram(o)uche	-	4/4/2004
2066	Rick >>We couldn't figure out if it was AN-9 itself, or a derivative	Icebrg	-	4/4/2004
2065	Erik: Miljenko and I once tried to track it down. We couldn't figure out i	scaram(o)uche	-	4/4/2004
2064	<i> butyrate. It's a short chain fatty acid, but is it approved for an	Biomaven	-	4/3/2004
2063	>> There are at least two HDAC inhibitors in clinical trials. >> Ma	Icebrg	-	4/3/2004
2062	There are at least two HDAC inhibitors in clinical trials. Aton's SAHA: >	tuck	-	4/3/2004
2061	Huh so MLNM is still in a range of $16-$18. I stated quite awhile ago that MDCO	Mike	-	4/3/2004
2060	<i>I don't think there is any approved HDI yet</i> There is an	Biomaven	-	4/2/2004
2059	Thanks!	keokalani'nui	-	4/1/2004
2058	During a Goldman Sachs conference call, MLNM was upbeat about its cancer program	PCSS	-	3/31/2004
2057	Erik, Many thanks. The lack of street interest now appears a little more logic	Ian@SI	-	3/31/2004
2056	Ian This was done in vitro and while encouraging it doesn't say much about	Icebrg	-	3/31/2004
2055	Hi Erik, Isn't this the first publication of a statistically significant r	Ian@SI	-	3/31/2004
2054	Combined proteasome and histone deacetylase inhibition in non-small cell lung ca	Icebrg	-	3/31/2004
2053	FYI - could move MLNM (+/-) today: <b>MLNM (IL/N): GS call 3/31 @10AM on	PCSS	-	3/31/2004
2052	>>Rinsho Ketsueki. 2004 Feb;45(2):144-8. [Article in Japanese] Tak	tuck	-	3/30/2004
2051	[Bortezomib and Flavopiridol against imatinib-resistant CML] >>Blood. 200	tuck	-	3/26/2004
2050	Somewhat along the same line Kenneth Andersson will present an overview at the u	Icebrg	-	3/22/2004
2049	Mimi review including survival baselines for MM: >>Lancet. 2004 Mar 13;36	tuck	-	3/22/2004
2048	J Med Chem. 2004 Mar 25;47(7):1602-1604. Identification of 2-{2-[2-(5-Bromo-2	scaram(o)uche	-	3/19/2004
2047	>>Semin Hematol. 2003 Oct;40(4 Suppl 4):33-8. Thalidomide and CC-5013	tuck	-	3/17/2004
2046	Millennium Announces FDA Selection of MLN2704 for Continuous Marketing Applicati	Icebrg	-	3/17/2004
2045	J. Clin. Invest. 113:856-866 (2004). doi:10.1172/JCI200420126. Copyright ©2	Miljenko Zuanic	-	3/16/2004

Go to reply# or date (mm/dd/yy):